IceCure Medical Ltd
ICCM
$1.13
-$0.025-2.17%
| 12/31/2024 | 06/30/2024 | 12/31/2023 | 09/30/2023 | ||
|---|---|---|---|---|---|
| Revenue | -- | -- | 4.67% | -17.48% | |
| Total Other Revenue | -- | -- | -- | -- | |
| Total Revenue | -- | -- | 4.67% | -17.48% | |
| Cost of Revenue | -- | -- | 17.62% | -9.56% | |
| Gross Profit | -- | -- | -10.03% | -26.74% | |
| SG&A Expenses | -- | -- | -5.05% | -4.60% | |
| Depreciation & Amortization | -- | -- | -- | -- | |
| Other Operating Expenses | -- | -- | -- | -- | |
| Total Operating Expenses | -- | -- | -5.14% | -2.36% | |
| Operating Income | -- | -- | 6.95% | -0.99% | |
| Income Before Tax | -- | -- | 13.70% | 3.56% | |
| Income Tax Expenses | -- | -- | -- | -- | |
| Earnings from Continuing Operations | -- | -- | 13.70% | 3.56% | |
| Earnings from Discontinued Operations | -- | -- | -- | -- | |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | |
| Minority Interest in Earnings | -- | -- | -- | -- | |
| Net Income | -- | -- | 13.70% | 3.56% | |
| EBIT | -- | -- | 6.95% | -0.99% | |
| EBITDA | -- | -- | 7.51% | -0.38% | |
| EPS Basic | -- | -- | 30.03% | 19.85% | |
| Normalized Basic EPS | -- | -- | 33.82% | 13.01% | |
| EPS Diluted | -- | -- | 30.03% | 19.85% | |
| Normalized Diluted EPS | -- | -- | 33.82% | 13.01% | |
| Average Basic Shares Outstanding | -- | -- | 23.29% | 21.71% | |
| Average Diluted Shares Outstanding | -- | -- | 23.29% | 21.71% | |
| Dividend Per Share | -- | -- | -- | -- | |
| Payout Ratio | -- | -- | -- | -- | |
